Is there a Single “Best” Platform or will it be “Fit to Purpose”?

Time: 10:00 am
day: Day Two


  • Analysing the advantages, disadvantages and comparisons of the DNA, Peptide, RNA, and Virus-based and other novel vaccine platforms
  • Harmonisation of clinical outcomes and immune correlates
  • Considering if we can we get better at predictive animal models?
  • Questioning what other signals we need to provide to the immune system, either built into the vaccine or given concomitantly (checkpoints, costims, cytokines, innate immunity boosters, etc.